Lv11
40 积分 2025-08-15 加入
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
9小时前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
10小时前
已完结
The impact of claudin-18.2 expression in patients with advanced gastric cancer treated with nivolumab
1天前
已完结
皖公网安备34019202002308
